ASX:MSB Archives

15/11/2021

MSB Share Price Up — Trial Drug Helps Against Heart Attacks (ASX:MSB)

Up-and-coming biotech player Mesoblast [ASX:MSB] is on the up today. The regenerative medicine company announced some promising results from a Phase III drug trial from data that was shared at the American Heart Association’s annual ‘Scientific Sessions’, an exhibition of the latest findings and insights into all things heart health related.

Kiryll Prakapenka

31/08/2021

Mesoblast Shares Tumble as Losses Widen (ASX:MSB)

The MSB share price down 14%. The Mesoblast [ASX:MSB] posted a FY21 net loss of $98.8 million as the FDA asks for further trials of MSB’s emergency COVID treatment...

Ryan Clarkson-Ledward

30/04/2021

Mesoblast Share Price Bounce Back on Positive Trial Data (ASX:MSB)

It seems 2021 continues to be a tough year for the ever-volatile Mesoblast Ltd [ASX:MSB]. Thankfully though, today has brought some relief to shareholders. The MSB share price is up 7.38%...

Ryan Clarkson-Ledward

02/03/2021

Mesoblast Share Price Down — Secures a Dire Cash Injection (ASX:MSB)

Seven months ago Mesoblast Ltd [ASX:MSB] was on a tear. This high-flying biotech looked like it had the makings of something great. Today though, that couldn't be further from the truth. The MSB share price is down 5.08%.

Ryan Clarkson-Ledward

18/12/2020

Mesoblast Share Price Crushed as Clinical Trial is Brought to a Halt

The Mesoblast Ltd [ASX:MSB] share price has been absolutely hammered today, trading 32.63% lower at time of writing. The result comes as the company shared some disheartening news. The trial of its remestemcel-L therapy...

Lachlann Tierney

15/12/2020

Mesoblast Share Price Crashes on Heart Failure Therapy Results

Mesoblast Ltd [ASX:MSB] shares have taken a heavy hit today on the back of phase three chronic heart failure results for its rexlemestrocel-L therapy. The Mesoblast share price has tracked fairly well this year...

Ryan Clarkson-Ledward

02/12/2020

Mesoblast Share Price Up on FDA ‘Fast Track’ Designation (ASX:MSB)

At time of writing the Mesoblast Ltd [ASX:MSB] share price is up 7.26%. Soaring on the back of some exciting news. Their remestemcel-L treatment has secured ‘fast track’ status from the US Food & Drug Administration (FDA)...

Lachlann Tierney

20/11/2020

Mesoblast Share Price Up on Novartis Collaboration (ASX:MSB)

At time of writing, the share price of Mesoblast Ltd [ASX:MSB] is up more than 14%, to trade at $3.73. We take a look at the details of Mesoblast’s latest announcement to work with pharma giant on remestemcel-L commercialisation

Carl Wittkopp

11/11/2020

Mesoblast Share Price Up on Encouraging COVID-19 Trails (ASX:MSB)

At time of writing, the Mesoblast Ltd [ASX:MSB] share price is up 4.47%, trading at $3.27. The MSB share price moved higher after announcing positive outcomes in relation to Remestemcel-L phase three trials...

Ryan Clarkson-Ledward

01/10/2020

Mesoblast Enters Trading Halt — Good News on the Horizon? (ASX:MSB)

It’s no secret that Mesoblast Ltd [ASX:MSB] has been a breakout mid-cap in 2020. The stock has seen close to a fivefold (500%) increase in its share price since the March crash. Delivering some astonishing gains to shareholders who stuck with the company...